QGEN Qiagen NV

  1. Stocks
  2. Healthcare
  3. NYSE: QGEN

Price (delayed)

$41.65

Market cap

$9.5B

P/E Ratio

27.77

Dividend/share

N/A

EPS

$1.5

Enterprise value

$10.35B

qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from ...

Highlights
The price to earnings (P/E) is 67% lower than the 5-year quarterly average of 83.1 and 9% lower than the last 4 quarters average of 30.4
The debt has declined by 19% year-on-year
Qiagen's EPS has decreased by 19% YoY but it has increased by 4.2% from the previous quarter
The company's net income fell by 19% YoY but it rose by 2.7% QoQ
Qiagen's quick ratio has decreased by 48% QoQ and by 26% YoY
The gross profit has contracted by 11% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.qiagen.com/
Peers: TMO HOLX BDX GE

Key stats

What are the main financial stats of QGEN
Market
Shares outstanding
228.2M
Market cap
$9.5B
Enterprise value
$10.35B
Valuations
Price to earnings (P/E)
27.77
Price to book (P/B)
2.42
Price to sales (P/S)
4.84
EV/EBIT
21.41
EV/EBITDA
15.03
EV/Sales
5.26
Earnings
Revenue
$1.97B
EBIT
$483.22M
EBITDA
$688.56M
Free cash flow
$309.75M
Per share
EPS
$1.5
Free cash flow per share
$1.36
Book value per share
$17.2
Revenue per share
$8.61
TBVPS
$13.64
Balance sheet
Total assets
$6.12B
Total liabilities
$2.31B
Debt
$1.51B
Equity
$3.81B
Working capital
$1.07B
Liquidity
Debt to equity
0.4
Current ratio
1.99
Quick ratio
1.33
Net debt/EBITDA
1.22
Margins
EBITDA margin
35%
Gross margin
62.8%
Net margin
17.4%
Operating margin
20.9%
Efficiency
Return on assets
5.5%
Return on equity
9.3%
Return on invested capital
14.1%
Return on capital employed
9.6%
Return on sales
24.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QGEN stock price

How has the Qiagen stock price performed over time
Intraday
1.39%
1 week
4.13%
1 month
-2.46%
1 year
-5.29%
YTD
-4.19%
QTD
-3.12%

Financial performance

How have Qiagen's revenue and profit performed over time
Revenue
$1.97B
Gross profit
$1.23B
Operating income
$409.94M
Net income
$341.3M
Gross margin
62.8%
Net margin
17.4%
Qiagen's operating income has decreased by 23% YoY
The company's net income fell by 19% YoY but it rose by 2.7% QoQ
The operating margin has declined by 16% year-on-year
The net margin has declined by 12% year-on-year but it has grown by 2.4% since the previous quarter

Growth

What is Qiagen's growth rate over time

Valuation

What is Qiagen stock price valuation
QGEN P/E details
P/E
27.77
P/B
2.42
P/S
4.84
EV/EBIT
21.41
EV/EBITDA
15.03
EV/Sales
5.26
The price to earnings (P/E) is 67% lower than the 5-year quarterly average of 83.1 and 9% lower than the last 4 quarters average of 30.4
Qiagen's EPS has decreased by 19% YoY but it has increased by 4.2% from the previous quarter
The stock's price to book (P/B) is 31% less than its 5-year quarterly average of 3.5 and 10% less than its last 4 quarters average of 2.7
QGEN's equity is up by 10% YoY and by 3.1% QoQ
QGEN's price to sales (P/S) is 10% lower than its 5-year quarterly average of 5.4 and 5% lower than its last 4 quarters average of 5.1
The company's revenue fell by 8% YoY

Efficiency

How efficient is Qiagen business performance
QGEN's ROE is down by 27% YoY
QGEN's return on assets is down by 18% year-on-year
The company's return on invested capital fell by 12% YoY but it rose by 7% QoQ
Qiagen's ROS has decreased by 8% YoY

Dividends

What is QGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QGEN.

Financial health

How did Qiagen financials performed over time
Qiagen's total assets is 165% higher than its total liabilities
Qiagen's quick ratio has decreased by 48% QoQ and by 26% YoY
The current ratio is down by 47% from the previous quarter and by 19% YoY
The debt is 60% smaller than the equity
Qiagen's debt to equity has decreased by 26% YoY
The debt has declined by 19% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.